当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Desmopressin
HUMAN COMPOUNDED DRUG
79926-014
Wedgewood Connect, LLC
2021/2/1 0:00:00
DESMOPRESSIN ACETATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.1 mg/1 mL
79926-014-03
Insulin
HUMAN COMPOUNDED DRUG
79926-017
Wedgewood Connect, LLC
2021/2/1 0:00:00
INSULIN GLARGINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 [iU]/1 mL
79926-017-05
Progesterone 50mg
HUMAN COMPOUNDED DRUG
26436-5062
Hybrid Pharma
2021/2/1 0:00:00
PROGESTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg
26436-5062-1
Progesterone 100mg
HUMAN COMPOUNDED DRUG
26436-5454
Hybrid Pharma
2021/2/1 0:00:00
PROGESTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg
26436-5454-1
Progesterone 35mg
HUMAN COMPOUNDED DRUG
26436-5470
Hybrid Pharma
2021/2/1 0:00:00
PROGESTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
35 mg
26436-5470-1
TESTOSTERONE 15
HUMAN COMPOUNDED DRUG
26436-5244
Hybrid Pharma
2021/2/1 0:00:00
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
150 mg/1 g
26436-5244-5
Testosterone Cypionate 20mg/mL
HUMAN COMPOUNDED DRUG
26436-5146
Hybrid Pharma
2021/2/1 0:00:00
TESTOSTERONE CYPIONATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
26436-5146-1
Trimix 60/30/3
HUMAN COMPOUNDED DRUG
26436-5097
Hybrid Pharma
2021/2/1 0:00:00
PAPAVERINE HYDROCHLORIDE; ALPROSTADIL; PHENTOLAMINE MESYLATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
30 mg/1 mL; 60 ug/1 mL; 3 mg/1 mL
26436-5097-5
Progesterone 175mg
HUMAN COMPOUNDED DRUG
26436-5363
Hybrid Pharma
2021/2/1 0:00:00
PROGESTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
175 mg
26436-5363-1
Sodium Citrate and Gentamicin Solution
HUMAN COMPOUNDED DRUG
71266-6660
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
TRISODIUM CITRATE DIHYDRATE; GENTAMICIN SULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
40 mg/1 mL; .32 mg/1 mL
71266-6660-4
Lidocaine HCl 2%
HUMAN COMPOUNDED DRUG
71266-9090
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
LIDOCAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
71266-9090-1
Atropine Sulfate
HUMAN COMPOUNDED DRUG
71266-2010
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
ATROPINE SULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.4 mg/1 mL
71266-2010-2
Atropine Sulfate
HUMAN COMPOUNDED DRUG
71266-2010
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
ATROPINE SULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.4 mg/1 mL
71266-2010-1
Ketamine
HUMAN COMPOUNDED DRUG
71266-9080
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
KETAMINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
71266-9080-1
Ketamine
HUMAN COMPOUNDED DRUG
71266-9080
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
KETAMINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
71266-9080-2
Ketoconazole
HUMAN COMPOUNDED DRUG
79926-022
Wedgewood Connect, LLC
2021/2/1 0:00:00
KETOCONAZOLE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg
79926-022-10
Cyclosporine
HUMAN COMPOUNDED DRUG
79926-004
Wedgewood Connect, LLC
2021/2/1 0:00:00
CYCLOSPORINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 mg/1 mL
79926-004-01
Tacrolimus
HUMAN COMPOUNDED DRUG
79926-006
Wedgewood Connect, LLC
2021/2/1 0:00:00
TACROLIMUS
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 mg/1 mL
79926-006-01
Tacrolimus
HUMAN COMPOUNDED DRUG
79926-007
Wedgewood Connect, LLC
2021/2/1 0:00:00
TACROLIMUS
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.3 mg/1 mL
79926-007-01
Tacrolimus
HUMAN COMPOUNDED DRUG
79926-009
Wedgewood Connect, LLC
2021/2/1 0:00:00
TACROLIMUS
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.3 mg/1 mL
79926-009-01
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3